# NICARDIPINE HYDROCHLORIDE
> **ANDA215377** · Abbreviated New Drug Application (Generic) · Sponsor: SENORES PHARMS · Approved 2023-07-17
## Drug
- **FDA Application Number:** ANDA215377
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NICARDIPINE HYDROCHLORIDE
- **Generic name:** NICARDIPINE HYDROCHLORIDE
- **Active ingredients:** NICARDIPINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SENORES PHARMS
- **Manufacturer:** Burel Pharmaceuticals, LLC
- **First approval:** 2023-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215377)
---
*MORVS · CC0 1.0*